The Journal Of Immunotherapy And Precision Oncology is a research journal that publishes research related to Biochemistry, Genetics and Molecular Biology; Immunology and Microbiology; Medicine. This journal is published by the Innovative Healthcare Institute. The ISSN of this journal is 26662345, 2590017X. Based on the Scopus data, the SCImago Journal Rank (SJR) of journal of immunotherapy and precision oncology is 0.393.
Also, please check the following important details about journal of immunotherapy and precision oncology: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.
According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.
The SJR (SCImago Journal Rank) measures citations weighted by prestige. It is useful for comparing journals within the same field, and forms the basis of the subject category ranking. A journal SJR indicator is a numeric value representing the average number of weighted citations received during a selected year per document published in that journal during the previous three years, as indexed by Scopus. Higher SJR indicator values are meant to indicate greater journal prestige. SJR is developed by the Scimago Lab, originated from a research group at University of Granada. Q1 journals are cited more often and by more prestigious journals than those in the other quartiles.
Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.
CiteScore of an academic journal is a measure reflecting the yearly average number of citations to recent articles published in that journal. This journal evaluation metric was launched in December 2016 by Elsevier as an alternative to the generally used JCR impact factors (calculated by Clarivate). CiteScore is based on the citations recorded in the Scopus database rather than in JCR, and those citations are collected for articles published in the preceding four years instead of two or five.
Source Normalized Impact per Paper (SNIP) is calculated annually from Scopus data. It is a sophisticated metric that intrinsically accounts for field-specific differences in citation practices.
Journal Title: | Journal of Immunotherapy and Precision Oncology |
Publisher: | Innovative Healthcare Institute |
ISSN: | 26662345, 2590017X |
Type: | journal |
Journal Scope: | Biochemistry, Genetics and Molecular Biology; Immunology and Microbiology; Medicine |
Country: | United States |
H-Index: | 7 |
SJR: | 0.393 |
Quartile: | Immunology and Allergy (Q3); Oncology (Q3); Cancer Research (Q4); Immunology (Q4) |
The journal of immunotherapy and precision oncology is indexed in:
An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.
The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).
The latest Quartile of journal of immunotherapy and precision oncology is Q3.
Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.
According to journal website, the publication fee of journal of immunotherapy and precision oncology is around 2400 USD.
The journal of immunotherapy and precision oncology has also Journal waiver policy (for developing countries, authors etc).
An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.
The Journal Publication Time means the average number of weeks between article submission and publication. According to the journal website, the journal of immunotherapy and precision oncology publishes research articles in 24 weeks on an average.
Visit to the official website of the journal/ conference to check the details about call for papers.
If your research is related to Biochemistry, Genetics and Molecular Biology; Immunology and Microbiology; Medicine, then visit the official website of journal of immunotherapy and precision oncology and send your manuscript.
SIMILIAR JOURNALS
INTERNATIONAL JOURNAL OF GENOMICS
ISSN: 2314-436XJOURNAL OF INTERFERON AND CYTOKINE RESEARCH
ISSN: 1079-9907TOP RESEARCH JOURNALS